UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046813
Receipt number R000053419
Scientific Title Exploratory research for induced sputum obtained from the subjects with COPD who participated in the TRACK study in Kurume University Hospital
Date of disclosure of the study information 2022/02/15
Last modified on 2023/08/07 13:49:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Exploratory research for the remaining clinical samples obtained from the subjects who participated in the TRACK study [Efficacy and safety of once-daily single-Inhaler TRiple (Trelegy Ellipta) therApy for Japanese with mild to moderate COPD in Kyushu] in Kurume University Hospital

Acronym

Exploratory research for the remaining clinical samples obtained from the subjects with COPD who participated in the TRACK study in Kurume University Hospital

Scientific Title

Exploratory research for induced sputum obtained from the subjects with COPD who participated in the TRACK study in Kurume University Hospital

Scientific Title:Acronym

Exploratory research for induced sputum in COPD

Region

Japan


Condition

Condition

COPD

Classification by specialty

Pneumology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Changes in induced sputum in patients with COPD after Triple therapy when compared with those after LAMA/LABA combination therapy

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Comparison of induced sputum pre- and post-treatment between triple and LAMA/LABA combination therapy

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Triple therapy

Interventions/Control_2

LAMA/LABA combination therapy

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

COPD

Key exclusion criteria

severe and very severe

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Tomotaka
Middle name -
Last name Kawayama

Organization

Kurume University School of Medicine

Division name

Department of Medicine

Zip code

8300011

Address

67 Asahi-machi, Kurume

TEL

0942317560

Email

kawayama_tomotaka@med.kurume-u.ac.jp


Public contact

Name of contact person

1st name Tomotaka
Middle name -
Last name Kawayama

Organization

Kurume University School of Medicine

Division name

Department of Medicine

Zip code

8300011

Address

67 Asahi-machi, Kurume

TEL

0942317560

Homepage URL

http://www.kurume-u.ac.jp/

Email

i_rinri@kurume-u.ac.jp


Sponsor or person

Institute

Kurume University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Kurume University School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Clinical research center in Kurume University

Address

67 Asahi-machi, Kurume

Tel

+81942317560

Email

i_rinri@kurume-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 02 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2021 Year 12 Month 01 Day

Date of IRB

2022 Year 01 Month 28 Day

Anticipated trial start date

2022 Year 02 Month 15 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 02 Month 03 Day

Last modified on

2023 Year 08 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053419